| Karen M Gisslen, CNM | |
|
1989 Miamisburg Centerville Rd, Suite 204, Centerville, OH 45459-3859 | |
| (937) 401-6822 | |
| (937) 401-6935 |
| Full Name | Karen M Gisslen |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 26 Years |
| Location | 1989 Miamisburg Centerville Rd, Centerville, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619352929 | NPI | - | NPPES |
| 0139677 | Medicaid | OH | |
| 000000947087 | Other | OH | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | COA06897NM (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grandview And Southview Hospitals | Dayton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dayton Osteopathic Hospital | 7618878877 | 24 |
News Archive
Two different genetic mutations cooperate to induce adrenal cancer, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center and University of Sao Paulo in Brazil.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
The drug thalidomide may have a new lease of life as a cancer treatment. A small study published in Gut suggests that it slows down the weight loss and wasting associated with advanced disease in patients with pancreatic cancer.
Fourteen drinks a week is linked with a higher risk of health problems including stroke and embolism in patients with atrial fibrillation, according to research published in EP Europace, a journal of the European Society of Cardiology.
› Verified 4 days ago
| Entity Name | Dayton Osteopathic Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588630347 PECOS PAC ID: 7618878877 Enrollment ID: O20040120000374 |
News Archive
Two different genetic mutations cooperate to induce adrenal cancer, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center and University of Sao Paulo in Brazil.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
The drug thalidomide may have a new lease of life as a cancer treatment. A small study published in Gut suggests that it slows down the weight loss and wasting associated with advanced disease in patients with pancreatic cancer.
Fourteen drinks a week is linked with a higher risk of health problems including stroke and embolism in patients with atrial fibrillation, according to research published in EP Europace, a journal of the European Society of Cardiology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen M Gisslen, CNM 1989 Miamisburg Centerville Rd, Suite 204, Miamisburg, OH 45342-3794 Ph: (937) 401-6822 | Karen M Gisslen, CNM 1989 Miamisburg Centerville Rd, Suite 204, Centerville, OH 45459-3859 Ph: (937) 401-6822 |
News Archive
Two different genetic mutations cooperate to induce adrenal cancer, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center and University of Sao Paulo in Brazil.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
The drug thalidomide may have a new lease of life as a cancer treatment. A small study published in Gut suggests that it slows down the weight loss and wasting associated with advanced disease in patients with pancreatic cancer.
Fourteen drinks a week is linked with a higher risk of health problems including stroke and embolism in patients with atrial fibrillation, according to research published in EP Europace, a journal of the European Society of Cardiology.
› Verified 4 days ago